This study sought to identify BRCA1 and BRCA 2 mutations among triple-negative breast cancer female patients in one of the major teaching and referral hospitals in Kenya, to inform an ongoing larger study on genetic mutation testing. Here, BRCA1 is linked to triple-negative breast carcinoma.